 Patients in the expansion cohort will receive quercetin treatment for the first 26 weeks. Patients who continue quercetin supplement clinically after 26 weeks, but discontinue quercetin before 1 year will be followed through the 1 year visit. Patients who discontinue quercetin supplement any time after the 1 year visit will be followed through the 2 year visit. 